High-performance liquid-chromatographic determination of warfarin enantiomers in plasma with automated on-line sample enrichment

被引:36
作者
Boppana, VK [1 ]
Schaefer, WH [1 ]
Cyronak, MJ [1 ]
机构
[1] GlaxoSmithKline, Drug Metab & Pharmacokinet, King Of Prussia, PA 19406 USA
来源
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS | 2002年 / 54卷 / 1-3期
关键词
semipermeable surface; R- and S-warfarins; fluorescence detection; column-switching valves;
D O I
10.1016/S0165-022X(02)00122-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive and selective chiral high performance liquid chromatographic method was developed for the direct determination of R- and S-warfarin enantiomers in human plasma. The method involved direct injection of human plasma onto a semipermeable surface (SPS) guard column, washing the proteins from the column with aqueous acetonitrile and back flushing the analytes onto a reversed phase ovomucoid silica HPLC column using switching valves. After separation, the analytes were simultaneously detected and quantitated with a fluorometer. The recoveries of R-warfarin from human plasma at 25 and 2500 ng/ml were 98.9% and 88.1%, respectively. The recoveries of S-warfarin at 25 and 2500 ng/ml were 105.4% and 93.9%, respectively. Using 100 mul of human plasma, the lower limit of quantification for both R- and S-warfarins was 25 ng/ml. Linear responses in analyte/intemal standard peak height ratios were observed for analyte concentrations ranging from 25 to 2500 ng/ml for both enantiomers. Fluorescence chromatograms of drug-free human plasma showed no interfering peaks with retention times similar to those for R- and S-warthrins and the internal standard. Results from a 3-day validation study for both enantiomers demonstrated excellent precision (1.7-9.0%) and accuracy (97-109%) across the calibration range. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:315 / 326
页数:12
相关论文
共 14 条
[1]   ENANTIOSELECTIVE ASSAY OF WARFARIN IN BLOOD-PLASMA BY LIQUID-CHROMATOGRAPHY ON CHIRALCEL OC [J].
ANDERSEN, C ;
BALMER, K ;
LAGERSTROM, PO .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 615 (01) :159-163
[2]   STEREOSPECIFIC FLUORESCENCE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF WARFARIN AND ITS METABOLITES IN PLASMA AND URINE [J].
BANFIELD, C ;
ROWLAND, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (10) :1392-1396
[3]   STEREOSPECIFIC HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF WARFARIN IN PLASMA [J].
BANFIELD, C ;
ROWLAND, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (08) :921-924
[4]   Direct plasma liquid chromatographic-tandem mass spectrometric analysis of granisetron and its 7-hydroxy metabolite utilizing internal surface reversed-phase guard columns and automated column switching devices [J].
Boppana, VK ;
MillerStein, C ;
Schaefer, WH .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 678 (02) :227-236
[5]   SENSITIVE STEREOSPECIFIC ASSAY OF WARFARIN IN PLASMA - REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC SEPARATION USING DIASTEREOISOMERIC ESTERS OF (-)-(1S,2R,4R)-ENDO-1,4,5,6,7,7-HEXACHLOROBICYCLO[2.2.1]-HEPT-5-ENE-2-CARBOXYLIC ACID [J].
CARTER, SR ;
DUKE, CC ;
CUTLER, DJ ;
HOLDER, GM .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 574 (01) :77-83
[6]   THE MEASUREMENT OF WARFARIN ENANTIOMERS IN SERUM USING COUPLED ACHIRAL CHIRAL, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY (HPLC) [J].
CHU, YQ ;
WAINER, IW .
PHARMACEUTICAL RESEARCH, 1988, 5 (10) :680-683
[7]   SEMIPERMEABLE-SURFACE REVERSED-PHASE MEDIA FOR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
DESILETS, CP ;
ROUNDS, MA ;
REGNIER, FE .
JOURNAL OF CHROMATOGRAPHY, 1991, 544 (1-2) :25-39
[8]   SEPARATION AND DETERMINATION OF WARFARIN ENANTIOMERS IN HUMAN PLASMA SAMPLES BY CAPILLARY ZONE ELECTROPHORESIS USING A METHYLATED BETA-CYCLODEXTRIN-CONTAINING ELECTROLYTE [J].
GAREIL, P ;
GRAMOND, JP ;
GUYON, F .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 615 (02) :317-325
[9]  
LAM YWF, 1988, PHARMACOTHERAPY, V8, P147
[10]   MEASUREMENT OF THE (R)-ISOMERS AND (S)-ISOMERS OF WARFARIN IN PATIENTS UNDERGOING ANTICOAGULANT-THERAPY [J].
MCALEER, SD ;
CHRYSTYN, H ;
FOONDUN, AS .
CHIRALITY, 1992, 4 (08) :488-493